Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts

TheFly reported connected April 13 that Leerink Partners began sum of ZBH with a Market Perform standing and a $10 terms target. The initiation noted that though the banal trades astatine a discount compared with large-cap aesculapian exertion peers and its ain humanities valuation range, the wide hazard and reward illustration is considered balanced. The steadfast highlighted constricted near-term upside imaginable up of much important catalysts expected successful 2027. It besides pointed to near-term maturation arsenic being delicate to shifts successful marketplace stock and pricing dynamics, which could constrain show comparative to expectations successful the abbreviated term.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) besides announced connected April 7 that it has appointed Jonathan M. Vigdorchik, M.D., arsenic Chief Science, Technology, and Medical Affairs Officer, effectual April 14, 2026. In this expanded enactment role, helium volition usher the company’s planetary exertion strategy crossed artificial intelligence, robotics, astute implant systems, and data-driven solutions.

He volition besides oversee aesculapian acquisition initiatives and the company’s planetary advisory board, supporting stronger objective engagement and innovation development. Dr. Vigdorchik, an orthopedic surgeon with anterior acquisition astatine ZBH, brings objective and probe expertise aimed astatine advancing orthopedic care. His assignment is intended to fortify the company’s innovation pipeline and accelerate the improvement of precocious surgical technologies.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is simply a planetary aesculapian instrumentality institution specializing successful orthopedic products, including associated replacement, sports medicine, and spine solutions. It develops precocious implants and surgical technologies designed to amended mobility and prime of beingness for patients.

While we admit the imaginable of ZBH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Healthcare Stocks to Buy and Hold for 3 Years and 10 Best Beaten Down Stocks to Invest successful According to Analysts.

Disclosure: None. Follow Insider Monkey connected Google News.